GENE ONLINE|News &
Opinion
Blog

TNBC
Role of Fatty Acids in Therapy Resistance for Triple-Negative Breast Cancer
2025-03-29
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Checkpoint Inhibitors as Part of Neoadjuvant Therapy in TNBC: Should We Use Them or Not?
2021-10-03
R&D
Recent Advances in Triple Negative Breast Cancer Treatments
2021-04-26
Roche’s Multifaceted Drug, Tecentriq Registers Mixed Results in Breast Cancer Patients
2020-09-22
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
AstraZeneca, Daiichi Sankyo Ink $6 Billion Deal for Lung and Breast Cancer Treatments
2020-07-28
Trodelvy Gives New Hope to Patients with Relapsing Breast Cancer
2020-07-09
R&D
ASCO 2020: Keytruda Chemo Combo Show Significant Benefit in PD-L1 Expressing mTNBC
2020-06-03
R&D
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
LATEST
Study Finds ADHD Prevalence Unchanged Amid Ongoing Medication Shortages
2025-06-18
FDA Panel Discusses Streamlining Drug Approvals for Rare Disease Therapies
2025-06-18
SCHOTT Pharma Allocates €100 Million to Boost RTU Sterile Cartridge Production Capacity
2025-06-18
European Commission Approves Fixed-Duration Regimen of Calquence and Venetoclax for Chronic Lymphocytic Leukemia
2025-06-18
Alvotech and Dr. Reddy’s Partner to Develop Biosimilar for Cancer Drug Pembrolizumab
2025-06-18
Atopic Dermatitis Market in Seven Major Global Regions Projected to Reach $22.4 Billion by 2033
2025-06-18
Servier India Launches Ivosidenib for AML and Cholangiocarcinoma Patients with IDH1 Mutation Following CDSCO Approval
2025-06-18
EVENT
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top